Gustav Brismark

Before starting his own business in 2019, Mr Brismark had over 30 years of experience from Research, Development of Wireless cellular standards and FRAND licensing, at Ericsson.  He started his career as a research engineer and inventor, on algorithm research for 2G cellular standards (GSM, US-TDMA and Japanese PDC) and later for 3G WCDMA. In the late 1990’s he was responsible for Ericsson’s standardisation acitvities in Japan, at the time when 3GPP was formed, enabling one global standard development activity for 3G WCDMA, with the endorsement of regional standards bodies worldwide.  From 2004-2019, Mr Brismark was part of the management of Ericsson’s IPR Licensing business. As the VP of IPR Strategy from 2006, part of his responsibility was IPR Policy matters and participation in ETSI IPR Special Committee as well as the Ad Hoc Group on IPR in ITU.  He served as the Chief Intellectual Property Officer (CIPO) at Ericsson, 2016-2019. As the CIPO Mr. Brismark was responsible for Ericsson’s worldwide patent licensing business and patent development.

In 2019 Mr Brismark founded Kazehara AB, providing consultancy services in IPR strategy, IPR value-creation, FRAND-licensing and eco-system development.  Since 2019, Mr Brismark has also been serving as a patent licensing expert witness in several patent litigation processes.

(Transcript) Protecting Intellectual Property for National Security: A Conversation with Rep. Nathaniel Moran (R-TX)

This transcript is from a CSIS and LeadershIP event hosted on December 3, 2024. Watch the full video here. John J. Hamre: Good afternoon, everybody. Welcome. We’re delighted to have you here. My name is John Hamre. I’m the president at CSIS. And this is going to be one
Read More

Generic Drugs, Property Rights, and the Orange Book

By Chris Borges Intellectual property (IP) rights secured through patents facilitate the introduction of dozens of new brand-name drugs and hundreds of generic drugs annually in the United States. However, proposals advanced by the Biden administration have mistakenly singled out patents as the cause of high drug prices, potentially harming the dense networks
Read More

Intellectual Property Rights and the Future of U.S. Technological Leadership

By Dr. Kirti Gupta This commentary is part of a report from the CSIS Economic Security and Technology Department, titled Staying Ahead in the Global Technology Race. The report features a set of essays outlining key issues on economic security for the next administration, including global technology competition, industrialization
Read More